Description
ZalcitABIne,alsoknownas2’,3’-dideoxycytidine,isanantiviralpyrimidinenucleosideanalogthatisclinicallyusedtotreatHIVinfection.ZalcitabineinhibitsreversetranscriptaseandpreventschainelongationwhenincorporatedintoviralDNA.
ZalcitABIne,alsoknownas2’,3’-dideoxycytidine,isanantiviralpyrimidinenucleosideanalogthatisclinicallyusedtotreatHIVinfection.ZalcitabineinhibitsreversetranscriptaseandpreventschainelongationwhenincorporatedintoviralDNA.
| CasNo. | 7481-89-2 |
|---|---|
| Purity | ≥98% |
| Formula | C9H13N3O3 |
| FormulaWt. | 211.22 |
| IUPACName | 4-amino-1-[(2R,5S)-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one |
| Synonym | Zalcitabine;ddCyd;Hivid |
| MeltingPoint | 215-217°C |
| Solubility | Moderatelysolubleinwater. |
| Appearance | WhitecrystalPowder |
| StoreTemp | Ambient |
|---|---|
| ShipTemp | Ambient |
| MSDS | D3212MSDSPDF |
|---|---|
| InfoSheet | D3212InfoSheetPDF |
| Brochures | AntiviralsBooklet |
SheltonMJ,O"DonnellAM,MorseGD.Zalcitabine.AnnPharmacother.1993Apr;27(4):480-9.PMID:8097417.
BalzariniJ.Anti-retroviralactivityandmolecular-biochemicalactionmechanismof2",3"-dideoxynucleosideanalogsand9-(2-phosphonylmethoxyethyl)purinederivatives.VerhKAcadGeneeskdBelg.1991;53(1):61-98.PMID:1647085.